In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133high to CD133low phenotype and reduces the CD133-related invasiveness
about
MRI Virtual Biopsy and Treatment of Brain Metastatic Tumors with Targeted Nanobioconjugates: Nanoclinic in the BrainHigh nuclear level of Vav1 is a positive prognostic factor in early invasive breast tumors: a role in modulating genes related to the efficiency of metastatic processCharacterization of the expression of the pro-metastatic Mena(INV) isoform during breast tumor progressionHIF-1-alpha links mitochondrial perturbation to the dynamic acquisition of breast cancer tumorigenicity.Evaluation of Breast Cancer Stem Cells and Intratumor Stemness Heterogeneity in Triple-negative Breast Cancer as Prognostic Factors.The CNGRCLLII(KLAKLAK)2 peptide shows cytotoxicity against HUVECs by inducing apoptosis: An in vitro and in vivo study.PLC-β2 is modulated by low oxygen availability in breast tumor cells and plays a phenotype dependent role in their hypoxia-related malignant potential.Prognostic Value of Cancer Stem Cells Markers in Triple-Negative Breast Cancer.Up-modulation of PLC-β2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133+/EpCAM+ phenotype: a promising target for preventing progression of TNBC.Long non-coding RNA MALAT-1 contributes to maintenance of stem cell-like phenotypes in breast cancer cells.Vav1 down-modulates Akt in different breast cancer subtypes: a new promising chance to improve breast cancer outcome.Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells.
P2860
Q29248327-07824A47-BE01-4787-844F-919E8E907926Q34100951-945723CB-3DDC-4D8C-88D6-A7AB566ED8E9Q36649864-C48043E6-AEE5-47C0-BE57-FEE128C5A0B2Q37376195-7232AFC1-5B13-4B48-B5EF-A9AD76C09AAAQ37513954-E845E693-B203-4598-9734-E4BB37BDC4CEQ38704717-94A0164B-98BE-41B5-BD6F-6399BE1EC42DQ40088702-9389445D-DBF7-42A8-8F77-891EA3A65E8EQ41182171-FAACAEDF-9C46-4541-BC0A-D3DDC0913424Q41611344-6CAA374F-87F4-4041-AD7A-BE3DB81710E2Q49946137-6B69ED5E-CCBF-49A0-9B9A-8D85D0B46637Q52586939-6B9AA68B-9F8F-4F76-9C6E-53989B5C0392Q55251624-0576320A-D61C-4AA3-BE16-4C8E0DD08612
P2860
In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133high to CD133low phenotype and reduces the CD133-related invasiveness
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In triple negative breast tumo ...... the CD133-related invasiveness
@en
In triple negative breast tumo ...... he CD133-related invasiveness.
@nl
type
label
In triple negative breast tumo ...... the CD133-related invasiveness
@en
In triple negative breast tumo ...... he CD133-related invasiveness.
@nl
prefLabel
In triple negative breast tumo ...... the CD133-related invasiveness
@en
In triple negative breast tumo ...... he CD133-related invasiveness.
@nl
P2093
P2860
P50
P356
P1433
P1476
In triple negative breast tumo ...... the CD133-related invasiveness
@en
P2093
Ervin Nika
Federica Brugnoli
Maria Palomba
Silvia Grassilli
P2860
P2888
P356
10.1186/1476-4598-12-165
P577
2013-12-13T00:00:00Z
P5875
P6179
1005283088